2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds...

Full description

Saved in:
Bibliographic Details
Main Authors LIENAU, PHILIP, KOPPITZ, MARCUS, VON NUSSBAUM, FRANZ, SIEMEISTER, GERHARD, LÜCKING, ULRICH, GRUDZINSKA-GOEBEL, JOANNA, BRIEM, HANS, EIS, KNUT, WENGNER, ANTJE-MARGRET, BONE, WILHELM, EBERSPÄCHER, UWE, LEFRANC, JULIEN, MOOSMAYER, DIETER, SCHICK, HANS, WORTMANN, LARS, BADER, BENJAMIN
Format Patent
LanguageEnglish
Polish
Published 31.01.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.
Bibliography:Application Number: PL20180167649T